(CBS) – A new vaccine may soon allow those who suffer from celiac disease to safely eat gluten.
The vaccine, NexVax2, uses the body’s own immune system to treat celiac disease.
Researchers believe if the vaccine is given in small amounts at first and the dosage is gradually increased, those who suffer from celiac disease will build up a resistance to the harmful protein in gluten without negative effects.
Those with celiac disease would still have to follow a gluten-free diet.
In 2017, the Massachusetts-based company, ImmusanT, received $40 million in financing to fund further research into NexVax2.
A year later, the first patient participating in a clinic trial received the vaccine and showed signs of progress.